Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter L Thompson

Showing results (51-60 of 140) with videos related to

Pageof 14
Sort By:
Stroke|May 25, 2004
Monocyte count, but not C-reactive protein or interleukin-6, is an independent risk marker for subclinical carotid atherosclerosisCaroline M L Chapman, John P Beilby, Brendan M McQuillan, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|August 5, 2004
Promoter polymorphism of the gene for CD14 receptor is not associated with sub-clinical carotid atherosclerosis in a community populationJoseph Hung, Brendan M McQuillan, Caroline M L Chapman, et al.
The Medical Journal of Australia|September 5, 2007
Patient delay in responding to symptoms of possible heart attack: can we reduce time to care?Judith C Finn, John H Nick Bett, Trevor R Shilton, et al.
Atherosclerosis|January 28, 2006
Interleukin-18 levels are not associated with subclinical carotid atherosclerosis in a community population. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS)Caroline M L Chapman, Brendan M McQuillan, John P Beilby, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 26, 2005
Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistanceJoseph Hung, Brendan M McQuillan, Caroline M L Chapman, et al.
Resuscitation|July 13, 2011
Effect of adrenaline on survival in out-of-hospital cardiac arrest: A randomised double-blind placebo-controlled trialIan G Jacobs, Judith C Finn, George A Jelinek, et al.
Journal of Clinical Nursing|October 6, 2016
Myocardial infarction, patient decision delay and help-seeking behaviour: a thematic analysisLinda L Coventry, Johanna W van Schalkwyk, Peter L Thompson, et al.
The Medical Journal of Australia|April 8, 2022
Emerging evidence for the use of colchicine for secondary prevention of coronary heart diseaseStefan M Nidorf, Jamie Layland, Philip C Robinson, et al.
American Heart Journal|June 25, 2004
Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: the Pravastatin in Acute Coronary Treatment (PACT) trialPeter L Thompson, Ian Meredith, John Amerena, et al.
Heart, Lung & Circulation|August 29, 2018
The Effect of Media Campaigns, Patient Characteristics, and Presenting Symptoms on Prehospital Delay in Myocardial Infarction Patients: A Prospective Cohort StudyLinda L Coventry, Alexandra P Bremner, Johanna W van Schalkwyk, et al.
Pageof 14

Showing results (51-60 of 140) with videos related to

Sort By:
Pageof 14
Stroke|May 25, 2004
Monocyte count, but not C-reactive protein or interleukin-6, is an independent risk marker for subclinical carotid atherosclerosisCaroline M L Chapman, John P Beilby, Brendan M McQuillan, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|August 5, 2004
Promoter polymorphism of the gene for CD14 receptor is not associated with sub-clinical carotid atherosclerosis in a community populationJoseph Hung, Brendan M McQuillan, Caroline M L Chapman, et al.
The Medical Journal of Australia|September 5, 2007
Patient delay in responding to symptoms of possible heart attack: can we reduce time to care?Judith C Finn, John H Nick Bett, Trevor R Shilton, et al.
Atherosclerosis|January 28, 2006
Interleukin-18 levels are not associated with subclinical carotid atherosclerosis in a community population. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS)Caroline M L Chapman, Brendan M McQuillan, John P Beilby, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 26, 2005
Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistanceJoseph Hung, Brendan M McQuillan, Caroline M L Chapman, et al.
Resuscitation|July 13, 2011
Effect of adrenaline on survival in out-of-hospital cardiac arrest: A randomised double-blind placebo-controlled trialIan G Jacobs, Judith C Finn, George A Jelinek, et al.
Journal of Clinical Nursing|October 6, 2016
Myocardial infarction, patient decision delay and help-seeking behaviour: a thematic analysisLinda L Coventry, Johanna W van Schalkwyk, Peter L Thompson, et al.
The Medical Journal of Australia|April 8, 2022
Emerging evidence for the use of colchicine for secondary prevention of coronary heart diseaseStefan M Nidorf, Jamie Layland, Philip C Robinson, et al.
American Heart Journal|June 25, 2004
Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: the Pravastatin in Acute Coronary Treatment (PACT) trialPeter L Thompson, Ian Meredith, John Amerena, et al.
Heart, Lung & Circulation|August 29, 2018
The Effect of Media Campaigns, Patient Characteristics, and Presenting Symptoms on Prehospital Delay in Myocardial Infarction Patients: A Prospective Cohort StudyLinda L Coventry, Alexandra P Bremner, Johanna W van Schalkwyk, et al.
Pageof 14